These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26926645)

  • 1. PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.
    Zeeman AM; Lakshminarayana SB; van der Werff N; Klooster EJ; Voorberg-van der Wel A; Kondreddi RR; Bodenreider C; Simon O; Sauerwein R; Yeung BK; Diagana TT; Kocken CH
    Antimicrob Agents Chemother; 2016 May; 60(5):2858-63. PubMed ID: 26926645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.
    Zeeman AM; van Amsterdam SM; McNamara CW; Voorberg-van der Wel A; Klooster EJ; van den Berg A; Remarque EJ; Plouffe DM; van Gemert GJ; Luty A; Sauerwein R; Gagaring K; Borboa R; Chen Z; Kuhen K; Glynne RJ; Chatterjee AK; Nagle A; Roland J; Winzeler EA; Leroy D; Campo B; Diagana TT; Yeung BK; Thomas AW; Kocken CH
    Antimicrob Agents Chemother; 2014; 58(3):1586-95. PubMed ID: 24366744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances.
    Deye GA; Gettayacamin M; Hansukjariya P; Im-erbsin R; Sattabongkot J; Rothstein Y; Macareo L; Fracisco S; Bennett K; Magill AJ; Ohrt C
    Am J Trop Med Hyg; 2012 Jun; 86(6):931-5. PubMed ID: 22665596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro.
    Maher SP; Vantaux A; Chaumeau V; Chua ACY; Cooper CA; Andolina C; Péneau J; Rouillier M; Rizopoulos Z; Phal S; Piv E; Vong C; Phen S; Chhin C; Tat B; Ouk S; Doeurk B; Kim S; Suriyakan S; Kittiphanakun P; Awuku NA; Conway AJ; Jiang RHY; Russell B; Bifani P; Campo B; Nosten F; Witkowski B; Kyle DE
    Sci Rep; 2021 Oct; 11(1):19905. PubMed ID: 34620901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The
    Gupta DK; Dembele L; Voorberg-van der Wel A; Roma G; Yip A; Chuenchob V; Kangwanrangsan N; Ishino T; Vaughan AM; Kappe SH; Flannery EL; Sattabongkot J; Mikolajczak S; Bifani P; Kocken CH; Diagana TT
    Elife; 2019 May; 8():. PubMed ID: 31094679
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety, Pharmacokinetics, and Activity of High-Dose Ivermectin and Chloroquine against the Liver Stage of Plasmodium cynomolgi Infection in Rhesus Macaques.
    Vanachayangkul P; Im-Erbsin R; Tungtaeng A; Kodchakorn C; Roth A; Adams J; Chaisatit C; Saingam P; Sciotti RJ; Reichard GA; Nolan CK; Pybus BS; Black CC; Lugo-Roman LA; Wegner MD; Smith PL; Wojnarski M; Vesely BA; Kobylinski KC
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrasting infection susceptibility of the Japanese macaques and cynomolgus macaques to closely related malaria parasites, Plasmodium vivax and Plasmodium cynomolgi.
    Tachibana S; Kawai S; Katakai Y; Takahashi H; Nakade T; Yasutomi Y; Horii T; Tanabe K
    Parasitol Int; 2015 Jun; 64(3):274-81. PubMed ID: 25316604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
    Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
    Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-relapse activity of mirincamycin in the Plasmodium cynomolgi sporozoite-infected Rhesus monkey model.
    Fracisco S; Teja-isavadharm P; Gettayacamin M; Berman J; Li Q; Melendez V; Saunders D; Xie L; Ohrt C
    Malar J; 2014 Oct; 13():409. PubMed ID: 25326032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin disrupts apicoplast biogenesis in replicating and dormant liver stages of the relapsing malaria parasites Plasmodium vivax and Plasmodium cynomolgi.
    Amanzougaghene N; Tajeri S; Franetich JF; Ashraf K; Soulard V; Bigeard P; Guindo CO; Bouillier C; Lemaitre J; Relouzat F; Legrand R; Kocken CHM; Zeeman AM; Roobsoong W; Sattabongkot J; Yang Z; Snounou G; Mazier D
    Int J Antimicrob Agents; 2024 May; 63(5):107112. PubMed ID: 38367843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of primaquine glyco-conjugates as potential tissue schizontocidal antimalarial agents.
    Azad CS; Saxena M; Siddiqui AJ; Bhardwaj J; Puri SK; Dutta GP; Anand N; Saxena AK
    Chem Biol Drug Des; 2017 Aug; 90(2):254-261. PubMed ID: 28102941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Causal prophylactic and radical curative activity of WR182393 (a guanylhydrazone) against Plasmodium cynomolgi in Macaca mulatta.
    Corcoran KD; Hansukjariya P; Sattabongkot J; Ngampochjana M; Edstein MD; Smith CD; Shanks GD; Milhous WK
    Am J Trop Med Hyg; 1993 Oct; 49(4):473-7. PubMed ID: 8214277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.
    Kocken CH; van der Wel A; Arbe-Barnes S; Brun R; Matile H; Scheurer C; Wittlin S; Thomas AW
    Exp Parasitol; 2006 Jul; 113(3):197-200. PubMed ID: 16458301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent Plasmodium vivax malaria due to dose-dependent primaquine resistance: a case report.
    Kristensen KL; Dragsted UB
    Scand J Infect Dis; 2014 Jan; 46(1):63-5. PubMed ID: 23957539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic spheroids used as an in vitro model to study malaria relapse.
    Chua ACY; Ananthanarayanan A; Ong JJY; Wong JY; Yip A; Singh NH; Qu Y; Dembele L; McMillian M; Ubalee R; Davidson S; Tungtaeng A; Imerbsin R; Gupta K; Andolina C; Lee F; S-W Tan K; Nosten F; Russell B; Lange A; Diagana TT; Rénia L; Yeung BKS; Yu H; Bifani P
    Biomaterials; 2019 Sep; 216():119221. PubMed ID: 31195301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical model to evaluate in vivo activities of antimalarial drugs in a Plasmodium cynomolgi-macaque model for Plasmodium vivax malaria.
    Kocken CH; Remarque EJ; Dubbeld MA; Wein S; van der Wel A; Verburgh RJ; Vial HJ; Thomas AW
    Antimicrob Agents Chemother; 2009 Feb; 53(2):421-7. PubMed ID: 19015340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Killing the hypnozoite--drug discovery approaches to prevent relapse in Plasmodium vivax.
    Campo B; Vandal O; Wesche DL; Burrows JN
    Pathog Glob Health; 2015 May; 109(3):107-22. PubMed ID: 25891812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neither the HIV protease inhibitor lopinavir-ritonavir nor the antimicrobial trimethoprim-sulfamethoxazole prevent malaria relapse in plasmodium cynomolgi-infected non-human primates.
    Hobbs CV; Dixit S; Penzak SR; Sahu T; Orr-Gonzalez S; Lambert L; Zeleski K; Chen J; Neal J; Borkowsky W; Wu Y; Duffy PE
    PLoS One; 2014; 9(12):e115506. PubMed ID: 25541998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of WR250417 (a proguanil analog) for causal prophylactic activity in the Plasmodium cynomolgi-Macaca mulatta model.
    Edstein MD; Corcoran KD; Shanks GD; Ngampochjana M; Hansukjariya P; Sattabongkot J; Webster HK; Rieckmann KH
    Am J Trop Med Hyg; 1994 Feb; 50(2):181-6. PubMed ID: 8116810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax.
    Spudick JM; Garcia LS; Graham DM; Haake DA
    J Clin Microbiol; 2005 Feb; 43(2):978-81. PubMed ID: 15695723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.